ClinicalTrials.gg
RecruitingNCT06188767Updated Apr 10, 2025

Testosterone-induced Muscle Memory and Underlying Mechanisms

An interventional study of Testosterone Undecanoate in Skeletal Muscle Physiology, sponsored by Morten Hostrup, PhD. Recruiting at 1 site in Denmark. Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-10.

Sponsored by Morten Hostrup, PhD · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Male
01

Study summary

The purpose of this project is to investigate underlying mechanisms of testosterone- and resistance training-induced muscle hypertrophy and muscle memory in humans.

02

Conditions studied

  • Skeletal Muscle Physiology
03

In context

Lead sponsor

Morten Hostrup, PhD is the lead sponsor of 17 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy men and women
  • of \<26 and normal and blood pressure

Exclusion criteria

Exclusion Criteria:

  • Smoking
  • Chronic disease,
  • Use of prescription medication
  • Pain due to current or previous musculoskeletal injury
  • Resistance training more than once per week in the 12 months leading up to the intervention
  • Current or previous use of prohibited anabolic substances
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Testosterone

    Participants are randomized to a single injection of 1000 mg testosterone undecanoate

    Drug: Testosterone Undecanoate

  • Placebo comparator
    Placebo

    Participants are randomized to a single placebo injection

    Drug: Testosterone Undecanoate

Interventions

  • Following testosterone/placebo injection, participants undergo supervised resistance training for 4 weeks. This period is followed by a washout period with no drug and either continued resistance training or detraining for 16 weeks. Thereafter, another 4-week period with supervised resistance training is commenced, with no drug.

06

What researchers measure

Primary outcomes

  1. Fiber cross-sectional area

    Immunohistochemistry to determine fiber cross-sectional area

    Time frame: The change in fiber cross-sectional is assessed at baseline, 4, 20 and 24 weeks

  2. Myonuclei

    Immunohistochemistry to determine number of myonuclei

    Time frame: The change in myonuclei is assessed at baseline, 4, 20 and 24 weeks

  3. Skeletal muscle proteome

    Pathway enrichment analysis of the muscle proteome using mass spectrometry-based proteomics

    Time frame: The change in the muscle proteome is assessed at baseline, 4, 20 and 24 weeks

Secondary outcomes

  1. Lean mass

    Lean mass assessed by dual X-ray absorptiometry (DXA)

    Time frame: The change in lean mass is assessed at baseline, 4, 20 and 24 weeks

  2. Satellite cells

    Immunohistochemistry to determine number of satellite cells

    Time frame: The change in satellite cells is assessed at baseline, 4, 20 and 24 weeks

  3. Muscle strength

    1-repetition maximum

    Time frame: The change in 1-repetition maximum is assessed at baseline, 4, 20 and 24 weeks

07

Study locations

1 of 1 sites recruiting
  • The August Krogh Section for Human and Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen
    Copenhagen, 2100, Denmark
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06188767
Lead sponsor
Morten Hostrup, PhD
Responsible party
Morten Hostrup, PhD (Associate Professor, University of Copenhagen) — Sponsor-investigator
First posted
Jan 3, 2024
Start date
Apr 1, 2025
Primary completion
Dec 1, 2027 (estimated)
Completion
Dec 1, 2028 (estimated)
Last update
Apr 10, 2025

Study contacts

Lukas Moesgaard
Contact
lm@nexs.ku.dk
+4561724440

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Testosterone undecanoate

Start the discussion